Vastly more important is preventing cognitive decline! Where is that protocol? Don't have it? Your complete stroke medical 'professionals' are utterly incompetent!
Assessments never do anything for recovery; you'll have to scream at your doctor for being totally incompetent!
StrokeCog-15 Is an Efficient Neuropsychological Battery to Screen for Cognitive Impairment in Chronic Stroke
Abstract
BACKGROUND:
Poststroke
cognitive impairment can significantly impact functional outcomes and
quality of life. While comprehensive neuropsychological evaluations are
valuable in characterizing this impairment, their time-intensive nature
is not always feasible. Thus, we set out to develop a brief cognitive
battery that is sensitive to poststroke cognitive impairment.
METHODS:
Neuropsychological
testing was completed in a validation sample of 126 participants with
chronic ischemic stroke (median days since stroke, 337 [interquartile
range, 235–1057]) as part of StrokeCog, a prospective observational
cohort study. This comprehensive 60-minute cognitive battery contained 9
tests covering 5 cognitive domains. A partial least square regression
analysis informed the selection of a brief, 15-minute battery of 4 tests
(StrokeCog-15) covering 4 cognitive domains: language, memory, working
memory, and processing speed/executive functioning. We then compared
StrokeCog-15 with Montreal Cognitive Assessment and an established
30-minute battery in its ability to detect cognitive impairment as
identified by the comprehensive battery. Finally, we assessed the
utility of StrokeCog-15 in an external validation sample of 61
participants (median days since stroke, 210 [interquartile range,
193–230]) enrolled in the parallel Stroke-IMPaCT study.
RESULTS:
Cognitive
impairment was common, occurring in 50% (n=61) and 66% (n=40) of the 2
cohorts. Deficits occurred most frequently in the memory and processing
speed/executive functioning domains. In the derivation sample,
StrokeCog-15 demonstrated high sensitivity (0.97) and adequate
specificity (0.78) in detecting cognitive impairment on the
comprehensive battery, outperforming both Montreal Cognitive Assessment
(sensitivity, 0.77; specificity, 0.73) and the 30-minute battery
(sensitivity, 0.97; specificity, 0.35). StrokeCog-15 similarly
demonstrated high sensitivity (0.93) and adequate specificity (0.67) in
the validation sample.
CONCLUSIONS:
A
brief 15-minute battery of tests has high sensitivity to detect
cognitive impairment as identified on a longer neuropsychological test
battery. StrokeCog-15 assesses multiple cognitive domains commonly
impacted by stroke and represents an efficient yet effective means to
identify chronic poststroke cognitive impairment.
Graphical Abstract
No comments:
Post a Comment